Drugs / hASC
last change Dec 2022 re-read 3 minutes ago

hASC

Cell therapy

Developed for
coronary artery disorder · myocardial ischemia

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT04005989 Comparator Dec 2021 → Nov 2022 coronary artery disorder, myocardial ischemia Hospital do Coracao Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hASC “hASC injection (1x10e6 / kg body weight)” NCT04005989 ↗
Modality Cell therapy “stem cell therapy” NCT04005989 ↗
Route Other “injecting different doses of hASC cells into the heart” NCT04005989 ↗